Most recently, APG-115 combined with BCL-2 inhibitor APG-2575 exhibited synergistic anti-proliferative and pro-apoptotic activities in DLBCL, AML, and ALL cells (Luo et al., 2020; Zhai et al., 2023). Here, BCL2 is linked to acute myeloid leukemia.